Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dbco-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 | 98.7% | 25 MG
SDP

Supplier:  Medchemexpress LLC HY13099025MG

Encompass_Preferred

DBCO-PEG4-Val-Cit-PAB-MMAF is a drug-linker conjugate used in antibody-drug conjugate research. It combines a cleavable PEG-based Val-Cit-PAB linker bearing a DBCO moiety with the tubulin inhibitor MMAF to enable enzyme-triggered payload release and bioorthogonal conjugation via SPAAC.

  • Cleavable Val-Cit-PAB linker for cathepsin-mediated payload release.
  • DBCO moiety enables SPAAC click chemistry with azide-functionalized partners.
  • Contains MMAF tubulin inhibitor as the cytotoxic payload.
  • High purity suitable for research use (approximately 98.7%).
  • Available in small research pack sizes such as 25 mg.

Catalog No. 50-002-02391


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.